Locations
Paris, France · New York, NY, USA · London, UK · Nantes, France · United States
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
201-1000 employees
Stage
Series B
founded in
2016
Owkin is an AI biotech company that integrates human and artificial intelligence to transform drug discovery and development. Founded in 2016, it focuses on identifying new drug candidates, de-risking and accelerating clinical trials, and building diagnostic solutions to improve patient outcomes. Owkin leverages a federated research network and multimodal patient data to enhance its AI models, making it a leader in the healthcare AI space. The company collaborates with top biopharma partners and academic institutions, utilizing cutting-edge technologies to deliver better drugs and diagnostics at scale. With a strong scientific advisory board and a commitment to open science, Owkin is positioned to make significant impacts in the field of personalized medicine.
Something looks off?On-site & Remote